Abstract:Lung CD4+ T cells accumulate as chronic obstructive pulmonary disease (COPD) progresses, but their role in pathogenesis remains controversial. To address this controversy, we studied lung tissue from 53 subjects undergoing clinically-indicated resections, lung volume reduction, or transplant. Viable single-cell suspensions were analyzed by flow cytometry or underwent CD4+ T cell isolation, followed either by stimulation with anti-CD3 and cytokine/chemokine measurement, or by real-time PCR analysis. In lung CD4+ T cells of most COPD subjects, relative to lung CD4+ T cells in smokers with normal spirometry: (a) stimulation induced minimal IFN-γ or other inflammatory mediators, but many subjects produced more CCL2; (b) the T effector memory subset was less uniformly predominant, without correlation with decreased IFN-γ production. Analysis of unstimulated lung CD4+ T cells of all subjects identified a molecular phenotype, mainly in COPD, characterized by markedly reduced mRNA transcripts for the transcription factors controlling TH1, TH2, TH17 and FOXP3+ T regulatory subsets and their signature cytokines. This mRNA-defined CD4+ T cell phenotype did not result from global inability to elaborate mRNA; increased transcripts for inhibitory CD28 family members or markers of anergy; or reduced telomerase length. As a group, these subjects had significantly worse spirometry, but not DLCO, relative to subjects whose lung CD4+ T cells expressed a variety of transcripts. Analysis of mRNA transcripts of unstimulated lung CD4+ T cell among all subjects identified two distinct molecular correlates of classical COPD clinical phenotypes: basal IL-10 transcripts correlated independently and inversely with emphysema extent (but not spirometry); by contrast, unstimulated IFN-γ transcripts correlated independently and inversely with reduced spirometry (but not reduced DLCO or emphysema extent). Aberrant lung CD4+ T cells polarization appears to be common in advanced COPD, but also exists in some smokers with normal spirometry, and may contribute to development and progression of specific COPD phenotypes. Trial registration: ClinicalTrials.gov as NCT00281229.

LSC - 2024 - Mucin overexpression in (pre-)COPD lung tissue correlates with degree of emphysema

Expression and Clinical Significance of Mucoprotein MUC5AC in Patients with Chronic Obstructive Pulmonary Disease

Expression of Epidermal Growth Factor Receptor and MUC5AC on Human Airway with Chronic Obstructive Pulmonary Disease

LSC Abstract – Systemic and Local Metabolomics Profiling Reveals Novel Insights into the Progression of Emphysema

Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease

MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model

Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes

Small Airway Disease in Pre-Chronic Obstructive Pulmonary Disease with Emphysema: A Cross-Sectional Study

Goblet Cell Hyperplasia and Abnormalities in Mucin Expression in COPD Patients

MUC5AC drives COPD exacerbation severity through amplification of virus-induced airway inflammation

Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients.

Metabolomics Screening Identifies Reducedl-Carnitine to Be Associated with Progressive Emphysema

Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD

Small airway determinants of airflow limitation in chronic obstructive pulmonary disease

Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent

Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease

Contribution of Emphysema and Small Airways in COPD

Relationship of Epidermal Growth Factor Receptor and Mucin Expression in Rats with Emphysema

The Characteristics and Clinical Significance of Mucin Levels in Bronchoalveolar Lavage Fluid of Patients with Interstitial Lung Disease.

Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD

The Association Between Small Airway Obstruction and Emphysema Phenotypes in COPD